Up-regulation of NOTCH4 gene expression in bipolar disorder

American Journal of Psychiatry

Volumn 169, Issue 12, 2012, Pages 1292-1300

  Dieset, Ingrid ^a   Djurovic, Srdjan ^a   Tesli, Martin ^a   Hope, Sigrun ^a   Mattingsdal, Morten ^a   Michelsen, Annika ^a   Joa, Inge ^a   Larsen, Tor Ketil ^a   Agartz, Ingrid ^a   Melle, Ingrid ^a   Røssberg, Jan Ivar ^a   Aukrust, Pål ^a   Andreassen, Ole A ^a   Ueland, Thor ^a  

^a not available ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; C REACTIVE PROTEIN; DNA; HEMOGLOBIN; HYPNOTIC AGENT; LAMOTRIGINE; LITHIUM; MESSENGER RNA; NEUROLEPTIC AGENT; NOTCH4 RECEPTOR;

ADULT; AGE; ANALYSIS OF COVARIANCE; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BODY MASS; CANNABIS ADDICTION; CAUCASIAN; CONFOUNDING VARIABLE; CONTROLLED STUDY; DEPRESSIVE PSYCHOSIS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INVENTORY OF DEPRESSIVE SYMPTOMS; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NOTCH4 GENE; PATHOGENESIS; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; UPREGULATION; YOUNG MANIA RATING SCALE;

EID: 84871839594     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2012.11091431     Document Type: Article

References (37)

1. Gershon ES, Alliey-Rodriguez N, Liu C: After GWAS: searching for genetic risk for schizophrenia and bipolar disorder. Am J Psychiatry 2011; 168:253 -256
2. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Suvisaari J, Lonnqvist J, Paunio T, Borglum AD, Hartmann A, Fink-Jensen A, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Bottcher Y, Olesen J, Breuer R, Moller HJ, Giegling I, Rasmussen HB, Timm S, Mattheisen M, Bitter I, Rethelyi JM, Magnusdottir BB, Sigmundsson T, Olason P, Masson G, Gulcher JR, Haraldsson M, Fossdal R, Thorgeirsson TE, Thorsteinsdottir U, Ruggeri M, Tosato S, Franke B, Strengman E, Kiemeney LA, Melle I, Djurovic S, Abramova L, Kaleda V, Sanjuan J, de Frutos R, Bramon E, Vassos E, Fraser G, Ettinger U, Picchioni M, Walker N, Toulopoulou T, Need AC, Ge D, Yoon JL, Shianna KV, Freimer NB, Cantor RM, Murray R, Kong A, Golimbet V, Carracedo A, Arango C, Costas J, Jonsson EG, Terenius L, Agartz I, Petursson H, Nothen MM, Rietschel M, Matthews PM, Muglia P, Peltonen L, St Clair D, Goldstein DB, Stefansson K, Collier DA: Common variants conferring risk of schizophrenia. Nature 2009; 460:744-747
3. O'Donovan MC, Craddock NJ, Owen MJ: Genetics of psychosis; insights from views across the genome. Hum Genet 2009; 126:3-12
4. Cichon S, Craddock N, Daly M, Faraone SV, Gejman PV, Kelsoe J, Lehner T, Levinson DF, Moran A, Sklar P, Sullivan PF; Psychiatric GWAS Consortium Coordinating Committee: Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry 2009; 166:540 -556
5. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P: Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460:748-752
6. Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS: Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry 2009; 70:1078 -1090
7. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E: Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 2008; 63:801-808 (Pubitemid 351410515)
8. Breunis MN, Kupka RW, Nolen WA, Suppes T, Denicoff KD, Leverich GS, Post RM, Drexhage HA: High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder. Biol Psychiatry 2003; 53:157 -165
9. Hope S, Melle I, Aukrust P, Agartz I, Lorentzen S, Steen NE, Djurovic S, Ueland T, Andreassen OA: Osteoprotegerin levels in patients with severe mental disorders. J Psychiatry Neurosci 2010; 35:304-310
10. Hope S, Melle I, Aukrust P, Steen NE, Birkenaes AB, Lorentzen S, Agartz I, Ueland T, Andreassen OA: Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar Disord 2009; 11:726-734
11. Williams HJ, Craddock N, Russo G, Hamshere ML, Moskvina V, Dwyer S, Smith RL, Green E, Grozeva D, Holmans P, Owen MJ, O'Donovan MC: Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Hum Mol Genet 2011; 20:387-391
12. Ikeda M, Aleksic B, Kinoshita Y, Okochi T, Kawashima K, Kushima I, Ito Y, Nakamura Y, Kishi T, Okumura T, Fukuo Y, Williams HJ, Hamshere ML, Ivanov D, Inada T, Suzuki M, Hashimoto R, Ujike H, Takeda M, Craddock N, Kaibuchi K, Owen MJ, Ozaki N, O'Donovan MC, Iwata N: Genome-wide association study of schizophrenia in a Japanese population. Biol Psychiatry 2011; 69:472-478
13. Radtke F, Fasnacht N, Macdonald HR: Notch signaling in the immune system. Immunity 2010; 32:14-27
14. Quillard T, Devalliere J, Coupel S, Charreau B: Inflammation dysregulates Notch signaling in endothelial cells: implication of Notch2 and Notch4 to endothelial dysfunction. Biochem Pharmacol 2010; 80:2032-2041
15. Maillard I, Adler SH, Pear WS: Notch and the immune system. Immunity 2003; 19:781-791 (Pubitemid 37542299)
16. Fung E, Tang SM, Canner JP, Morishige K, Arboleda-Velasquez JF, Cardoso AA, Carlesso N, Aster JC, Aikawa M: Delta-like 4 induces notch signaling in macrophages: implications for inflammation. Circulation 2007; 115:2948-2956 (Pubitemid 46912098)
17. Murphy PA, Lu G, Shiah S, Bollen AW, Wang RA: Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease. Lab Invest 2009; 89:971- 982
18. Howie BN, Donnelly P, Marchini J: A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009; 5:e1000529
19. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-575 (Pubitemid 47330214)
20. Ringen PA, Lagerberg TV, Birkenaes AB, Engn J, Faerden A, Jónsdottir H, Nesvåg R, Friis S, Opjordsmoen S, Larsen F, Melle I, Andreassen OA: Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder. Psychol Med 2008; 38:1241 -1249
21. Bello G, Cailotto F, Hanriot D, Kolopp-Sarda MN, Latger-Cannard V, Hess K, Zannad F, Longrois D, Ropars A: C-reactive protein (CRP) increases VEGF-A expression in monocytic cells via a PI3-kinase and ERK 1/2 signaling dependent pathway. Atherosclerosis 2008; 200:286-293
22. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, Badiwala MV, Mickle DA, Weisel RD, Fedak PW, Stewart DJ, Kutryk MJ: C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004; 109:2058-2067 (Pubitemid 38620212)
23. Funahashi Y, Shawber CJ, Sharma A, Kanamaru E, Choi YK, Kitajewski J: Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity. Vasc Cell 2011; 3:2
24. Brietzke E, Stertz L, Fernandes BS, Kauer-Sant 'anna M, Mascarenhas M, Escosteguy Vargas A, Chies JA, Kapczinski F: Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 2009; 116:214-217
25. Demjaha A, Maccabe JH, Murray RM: How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder. Schizophr Bull 2012; 38:209-214
26. Kume T: Novel insights into the differential functions of Notch ligands in vascular formation. J Angiogenes Res 2009; 1:8
27. Iso T, Hamamori Y, Kedes L: Notch signaling in vascular development. Arterioscler Thromb Vasc Biol 2003; 23:543- 553
28. Greenberg DA, Jin K: From angiogenesis to neuropathology. Nature 2005; 438:954-959 (Pubitemid 43093961)
29. Higgs BW, Elashoff M, Richman S, Barci B: An online database for brain disease research. BMC Genomics 2006; 7:70
30. Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T: Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 2004; 9:406-416 (Pubitemid 38534701)
31. Hayward P, Kalmar T, Arias AM: Wnt/Notch signaling and information processing during development. Development 2008; 135:411-424
32. Johnson MA, Ables JL, Eisch AJ: Cell-intrinsic signals that regulate adult neurogenesis in vivo: insights from inducible approaches. BMB Rep 2009; 42:245-259
33. Liebner S, Plate KH: Differentiation of the brain vasculature: the answer came blowing by the Wnt. J Angiogenes Res 2010; 2:1
34. Zandi PP, Belmonte PL, Willour VL, Goes FS, Badner JA, Simpson SG, Gershon ES, McMahon FJ, DePaulo JR Jr, Potash JB, Bipolar Disorder Phenome Group; National Institute of Mental Health Genetics Initiative Bipolar Disorder Consortium: Association study of Wnt signaling pathway genes in bipolar disorder. Arch Gen Psychiatry 2008; 65:785-793
35. Pedroso I, Lourdusamy A, Rietschel M, Nothen MM, Cichon S, McGuffin P, Al-Chalabi A, Barnes MR, Breen G: Common genetic variants and gene-expression changes associated with bipolar disorder are over-represented in brain signaling pathway genes. Biol Psychiatry 2012; 72:311-317
36. Han J, Hendzel MJ, Allalunis-Turner J: Notch signaling as a therapeutic target for breast cancer treatment? Breast Cancer Res 2011; 13:210
37. Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhães PV, Amminger P, McGorry P, Malhi GS: Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011; 35:804-817